INmune Bio
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INmune Bio and other ETFs, options, and stocks.About INMB
INmune Bio, Inc. is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprogram the immune system to fight cancer and Alzheimer’s disease. The company was founded by Mark Lowdell on September 25, 2015 and is headquartered in Boca Raton, FL.
INMB Key Statistics
Stock Snapshot
As of today, INmune Bio(INMB) shares are valued at $1.65. The company's market cap stands at 45.66M, with a P/E ratio of -2.38.
As of 2026-10-16, INmune Bio(INMB) stock has fluctuated between $1.53 and $1.68. The current price stands at $1.65, placing the stock +7.8% above today's low and -1.8% off the high.
The INmune Bio(INMB)'s current trading volume is 628.02K, compared to an average daily volume of 352.87K.
During the past year, INmune Bio(INMB) stock moved between $1.09 at its lowest and $2.60 at its peak.
During the past year, INmune Bio(INMB) stock moved between $1.09 at its lowest and $2.60 at its peak.
INMB News
...
INmune Bio (INMB) and Quantum Computing (QUBT) announced a collaboration to apply quantum computing, artificial intelligence, or AI, and data analytics to ident...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.